Related Experiment Video
Updated: Jan 31, 2026

High-throughput Screening for Protein-based Inheritance in S. cerevisiae
Published on: August 8, 2017
Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques
Galaxy Y Cho1,2,3, Kyle Bolo4, Karen Sophia Park1,2
1Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, New York, USA.
Abstract:
Inherited retinal dystrophies cause progressive vision loss and are major contributors to blindness worldwide. Advances in gene therapy have brought molecular approaches into the realm of clinical trials for these incurable illnesses. Select phase I, II and III trials are complete and provide some promise in terms of functional outcomes and safety, although questions do remain over the durability of their effects and the prevalence of inflammatory reactions. This article reviews gene therapy as it can be applied to inherited retinal dystrophies, provides an update of results from recent clinical trials, and discusses the future prospects of gene therapy and genome surgery.
Insights
Gene therapy offers promising results for inherited retinal dystrophies, a leading cause of blindness. Ongoing clinical trials show potential for vision restoration, but long-term durability and inflammation require further study.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Inherited retinal dystrophies (IRDs) are a significant cause of global blindness.
- Current treatments for IRDs are limited, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review the application of gene therapy for IRDs.
- To update on recent clinical trial outcomes.
- To discuss future directions in gene therapy and genome surgery for retinal diseases.
Main Methods:
- Review of completed Phase I, II, and III clinical trials for gene therapy in IRDs.
- Analysis of reported functional outcomes and safety profiles.
- Discussion of emerging technologies like genome surgery.
Main Results:
- Gene therapy trials demonstrate promise in improving functional vision and safety.
- Durability of therapeutic effects and inflammatory responses remain areas for continued investigation.
- Recent trials provide valuable data on the efficacy and tolerability of gene augmentation strategies.
Conclusions:
- Gene therapy is a rapidly advancing field with significant potential for treating IRDs.
- Further research is needed to optimize treatment protocols and address long-term challenges.
- Gene therapy and genome surgery represent the future of inherited blindness treatment.
More Related Videos
08:53Methylnitrosourea MNU-induced Retinal Degeneration and Regeneration in the Zebrafish: Histological and Functional Characteristics
Published on: October 20, 2014
06:27Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
Published on: October 27, 2017
Related Concept Videos
Chromosomal Theory of Inheritance
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Inheritance of Chromatin Structures
Non-nuclear Inheritance
Inheritance
Each gene exists in pairs, and the combination of these genes from both parents forms an individual's genotype. This genotype is a blueprint of potential traits. Examples of genotype...